Skip to content
Study details
Enrolling now

RELAXaHEAD for Headache Patients (Phase III)

NYU Langone Health
NCT IDNCT06077838ClinicalTrials.gov data as of Apr 2026
Target enrollment

356

Study length

about 4.8 years

Ages

16–80

Locations

1 site in NY

About this study

Researchers are testing a treatment called RELAXaHEAD, which is a smartphone app, to help people with migraine. The trial will last 1758 days and involve 356 participants who have migraines seen across different healthcare settings. Researchers will compare the two versions of the RELAXaHEAD app to see if they are effective.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in RELAXaHEAD Smartphone App Version 1
  • 2.Participate in RELAXaHEAD Smartphone App Version 2
Primary goalChange from Baseline in Modified Monthly Migraine Disability Assessment Scale (mMIDAS) Score

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low7%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Change from Baseline in Modified Monthly Migraine Disability Assessment Scale (mMIDAS) Score

Secondary: Change in Migraine Specific Quality of Life (MSQ) Version 2 Scores

Body systems

Neurology